WO2023234116A1

WO2023234116A1 - Skin treatment device, operation method for operating skin treatment device, skin treatment method and program

Info

Publication number: WO2023234116A1
Application number: PCT/JP2023/019128
Authority: WO
Inventors: 謙太朗山▲崎▼
Original assignee: ヤーマン株式会社
Priority date: 2022-05-31
Filing date: 2023-05-23
Publication date: 2023-12-07

Abstract

Disclosed are: an operation method for operating a skin treatment device for treating the skin of a person in a manner such that a target substance which can be imparted to the skin of the person penetrates therein; a skin treatment device for treating the skin of a person in a manner such that a target substance which can be imparted to the skin of the person penetrates therein; or a program for treating the skin of a person in a manner such that a target substance which can be imparted to the skin of the person penetrates therein.

Description

Skin treatment device, operating method for operating the skin treatment device, skin treatment method, program

The present disclosure relates to a skin treatment device, an operating method for operating the skin treatment device, a skin treatment method, and a program.

There is a known technology that makes it easy to obtain information on the ingredients of cosmetics to be used, and allows users to select cosmetics and create cosmetic recipes that meet their needs.

Japanese Patent Application Publication No. 2001-357140

However, with the above-mentioned conventional techniques, it is not possible to control the skin treatment device in a control manner suitable for the various components contained in cosmetics and the like.

Therefore, an object of the present disclosure is to make it possible to control a skin treatment device in a control manner suitable for a target object.

In one aspect, a method of operating a skin treatment device for treating a person's skin is disclosed such that an object that can be applied to the person's skin penetrates the skin.

According to the present disclosure, it is possible to control the skin treatment device in a control manner suitable for the target object.

1 is a diagram showing an outline of the configuration of an information processing system according to an embodiment. FIG. 2 is a block diagram showing the hardware configuration of an information processing device. FIG. 1 is a diagram showing the appearance of a beauty device according to an example. It is a schematic block diagram of the control system with which the beauty device by example is equipped. FIG. 2 is an explanatory diagram illustrating an example of data related to control information, which is data stored in the storage unit of the information processing device according to the present embodiment. FIG. 6 is an explanatory diagram of repetition information in FIG. 5; FIG. 3 is a diagram showing an example of an output waveform in one output mode. 8 is a diagram showing other output waveforms that may be used instead of the output waveform of output mode M1 shown in FIG. 7. FIG. 8 is a diagram showing other output waveforms that may be used instead of the output waveform of output mode M1 shown in FIG. 7. FIG. 8 is a diagram showing other output waveforms that may be used instead of the output waveform of output mode M1 shown in FIG. 7. FIG. FIG. 7C is an enlarged view of section Q6 in FIG. 7C. FIG. 7 is a diagram showing an example of an output waveform in another output mode. FIG. 7 is a diagram showing an example of an output waveform in yet another output mode. FIG. 7 is a diagram showing an example of an output waveform in yet another output mode. FIG. 7 is a diagram showing an example of an output waveform in yet another output mode. FIG. 3 is a table showing an example of control information for each specific object. 3 is a timing chart schematically showing an example of the operation of the information processing system. 6 is a diagram showing data according to another embodiment that can be used instead of the data (data related to control information) shown in FIG. 5. FIG. 15 is an explanatory diagram of a specific example of control information related to the example shown in FIG. 14. FIG. FIG. 2 is a diagram showing test results when a specific output waveform is applied to a specific target "magnesium ascorbyl phosphate." FIG. 3 is a table showing other test results regarding the specific target "magnesium ascorbyl phosphate." FIG. 3 is a diagram showing test results when a specific output waveform is applied to a specific target "niacinamide (vitamin B3)." It is a table showing other test results regarding the specific target substance "tranexamic acid." FIG. 3 is a table showing other test results regarding the specific target "niacinamide." FIG. 2 is a table showing other test results regarding the specific target "kojic acid." FIG. 3 is a table showing other test results regarding the specific target “arbutin”. FIG. 3 is a table showing other test results regarding the specific target "phenylethylresorcinol." FIG. 3 is a table showing other test results regarding the specific target "hydrolyzed collagen." FIG. 2 is a table showing other test results regarding the specific target "collagen peptide." FIG. 2 is a table showing other test results regarding the specific target "tocopherol acetate." FIG. 3 is an explanatory diagram of a control mode when a plurality of pieces of control information are used simultaneously.

Hereinafter, this embodiment will be described using the drawings. Various features shown in the examples below can be combined with each other.

The program for realizing the software appearing in this embodiment may be provided as a non-transitory computer-readable medium, or may be downloadable from an external server. Alternatively, the program may be provided in such a way that the program is started on an external computer and the function is realized on the client terminal (so-called cloud computing).

Furthermore, in this embodiment, the term "unit" may include, for example, a combination of hardware resources implemented by circuits in a broad sense and software information processing that can be concretely realized by these hardware resources. . In addition, various types of information are handled in this embodiment, and these information include, for example, the physical value of a signal value representing voltage and current, and the signal value as a binary bit collection consisting of 0 or 1. It is expressed by high and low levels or quantum superposition (so-called quantum bits), and communication and calculations can be performed on circuits in a broad sense.

Further, a circuit in a broad sense is a circuit realized by at least appropriately combining a circuit, a circuit, a processor, a memory, and the like. That is, Application Specific Integrated Circuit (ASIC), programmable logic device (for example, Simple Programmable Logic Device (SPLD)), complex programmer Complex Programmable Logic Device (CPLD) and field This includes a field programmable gate array (FPGA) and the like.

Furthermore, in this specification, the term "correspondence" includes not only direct correspondence but also indirect correspondence. For example, the state in which element A is associated with element B is not only the state in which element A is associated with element B, but also the state in which element A is associated with element C, and element B is associated with element C. It is a concept that also includes the state of being

FIG. 1 is a diagram showing an outline of the configuration of an information processing system 1 according to the present embodiment.

The information processing system 1 includes a user terminal 2, an information processing device 3, and a beauty device 4, which are configured to be able to communicate through a telecommunications line. In other words, the information processing device 3 is configured to be able to communicate with the user terminal 2 and the beauty device 4 via the network. Here, the system exemplified by the information processing system 1 is composed of one or more devices or components.

The user terminal 2 has a communication section, a storage section, a control section, a display section, an input section, and an imaging section, and these components are electrically connected inside the user terminal 2 via a communication bus. It is connected to the. Descriptions of the communication unit, storage unit, and control unit will be omitted because they are substantially the same as the communication unit 31, storage unit 32, and control unit 33 in the information processing device 3.

The display unit may be included in the housing of the user terminal 2, or may be attached externally, for example. The display unit displays a graphical user interface (GUI) screen that can be operated by a user. It is preferable that such a display unit is implemented by using display devices such as a CRT display, a liquid crystal display, an organic EL display, and a plasma display depending on the type of user terminal 2, for example. Here, the display unit will be described as being included in the casing of the user terminal 2.

The input unit may be included in the casing of the user terminal 2 or may be externally attached. For example, the input section may be integrated with the display section and implemented as a touch panel. With a touch panel, the user can input tap operations, swipe operations, and the like. Of course, a switch button, a mouse, a QWERTY keyboard, etc. may be used instead of the touch panel. That is, the input unit receives operation inputs made by the user. The input is transferred as a command signal to the control unit via the communication bus, and the control unit can execute predetermined control or calculation as necessary.

The imaging unit is a so-called vision sensor (camera) that is configured to be able to capture information from the outside world. The imaging unit is configured to generate image data by photographing an object. The imaging unit is connected via a network to a communication unit 31 in the information processing device 3, which will be described later, and is configured to be able to transfer captured image data to the information processing device 3.

FIG. 2 is a block diagram showing the hardware configuration of the information processing device 3. The information processing device 3 may be in the form of a server computer, for example. The information processing device 3 may be realized by a plurality of server computers.

The information processing device 3 includes a communication unit 31, a storage unit 32, and a control unit 33, and these components are electrically connected via a communication bus 30 inside the information processing device 3. .

Although the communication unit 31 is preferably a wired communication means such as USB, IEEE1394, Thunderbolt (registered trademark), wired LAN network communication, etc., it is also suitable for wireless LAN network communication, mobile communication such as 3G/LTE/5G, Bluetooth (registered trademark) Communication etc. may be included as necessary. That is, it is more preferable that the communication unit 31 is implemented as a set of these plurality of communication means. That is, the information processing device 3 communicates various information via the communication unit 31 with the user terminal 2 and the beauty device 4 via the network.

The storage unit 32 may be formed by any storage medium and stores various information defined by the above description. The storage unit 32 may be used, for example, as a storage device such as a solid state drive (SSD) that stores various programs related to the information processing device 3 executed by the control unit 33, or as a storage device related to program calculations. It can be implemented as a memory such as a random access memory (RAM) that temporarily stores necessary information (arguments, arrays, etc.). Furthermore, the storage unit 32 may be a combination of these. In particular, the storage unit 32 stores various programs related to the information processing device 3 that are executed by the control unit 33. Note that the storage unit 32 does not need to be built into the information processing device 3 and may be provided outside the information processing device 3. In this case, the storage unit 32 may be realized by a storage device that can be accessed by the information processing device 3 via a network.

The control unit 33 processes and controls the overall operation related to the information processing device 3. The control unit 33 is, for example, a central processing unit (CPU) not shown. The control unit 33 implements various functions related to the information processing device 3 by reading predetermined programs stored in the storage unit 32. That is, various functions related to the information processing device 3 are realized by concretely realizing information processing by software stored in the storage unit 32 by the control unit 33, which is an example of hardware. Note that the control section 33 is not limited to a single control section, and may be implemented so as to have a plurality of control sections 33 for each function. Further, the control section 33 may be a combination of a plurality of control sections.

FIG. 3 is a diagram showing the appearance of the beauty device 4 according to an example. The beauty device 4 includes an operating section 4a and a grip section 4b.

The beauty device 4 is composed of an operating section 4a and a grip section 4b that is a support for the operating section 4a. The operating section 4a is configured to operate in contact with the user's skin, and is provided at one longitudinal end of the grip section 4b. The skin with which the operating portion 4a comes into contact includes, for example, the skin of the upper body. Here, the upper body includes at least one of the area around the face, the area around the neck, and the area around the chest. In other words, it refers to the skin above the décolletage on the upper body. For example, the face, chin, neck, collarbone, chest, head, etc. Note that the area is not necessarily limited to the above-mentioned areas, but may include the rear neck, abdomen, back, waist, and arms, and may also include the lower body such as the buttocks and legs.

A plurality of electrodes may be provided in the operating section 4a. In this case, various output waveforms can be applied to the skin via one or more arbitrary or predetermined pairs of electrodes among the plurality of electrodes. In the example shown in FIG. 3, as an example, the plurality of electrodes 40 are arranged on a circular arc. Note that the arrangement and number of electrodes 40 are arbitrary, and any structure may be used as long as at least two or more electrodes are arranged. Further, in specific processing such as iontophoresis, a hand electrode (not shown) that can be placed on the grip portion 4b may be used.

The grip portion 4b is a rod-shaped portion that is grasped by the user. The grip portion 4b may be provided with an operation button 4c that is operated by the user when starting or ending the operation of the beauty device 4 or when changing the operation mode.

(control system)
FIG. 4 is a schematic configuration diagram of a control system 100 included in the beauty device 4 according to an example.

In the example shown in FIG. 4, the control system 100 includes a control device 110 and an electric circuit section 200, and the electric circuit section 200 includes a drive circuit section 120, an output waveform generation section 130, and a switching circuit section 140. include.

The control device 110 includes a computer, and may be formed by a microcomputer, for example. Note that the control device 110 may operate based on power from the power source 150.

Based on the control information, the control device 110 controls the drive circuit section 120, the output waveform generation section 130, and the switching circuit section 140 so that output waveforms corresponding to the control information are generated from the plurality of electrodes 40.

The control information is any information that characterizes the output waveform of the output via the plurality of electrodes 40. Further, the control information is any information used by the control device 110 to output a desired output waveform via the plurality of electrodes 40, and may include information used at any stage. For example, the control information may be control signals CT1 and CT2 described later, the signal itself from the drive circuit section 120 to the output waveform generation section 130, or various information for generating these signals. good. An example of the control information will be described later.

In the example shown in FIG. 4, the drive circuit section 120 generates various output waveforms via the plurality of electrodes 40. FIG. 4 schematically shows part of the waveforms of the control signals CT1 and CT2. In this case, the control signals CT1 and CT2 may be applied to the drive circuit section 120 via separate control lines L1 and L2, respectively. The frequencies (duty ratios) of the control signals CT1 and CT2 may be determined according to control information (value of the second parameter), which will be described later.

The drive circuit section 120 includes a driver that drives a plurality of switching elements Tr, which will be described later. The drive circuit section 120 generates a drive signal for turning on/off the switching element Tr of the output waveform generation section 130 according to the control signals CT1 and CT2 from the control device 110, respectively, and transfers the generated drive signal to a corresponding one. is applied to the switching element Tr.

The output waveform generators 130 each generate an output waveform based on a power source 150 that is a DC power source. Output waveform generating section 130 includes a pair of switching elements Tr and a transformer 135.

The pair of switching elements Tr are switching elements such as transistors, for example, and one is connected to the terminal Ta of the transformer 135, and the other is connected to the terminal Tb of the transformer 135. In the transformer 135, a power source 150 is connected to a terminal Tc related to a center tap. The transformer 135 has a frequency specification adapted to a predetermined frequency. For example, when the induced voltage E of the transformer 135 is E=√2·π·f·n·φm, the frequency f may be set to be substantially equal to a predetermined frequency. Note that in this case, n is the number of turns, and φm is the magnetic flux. Note that the transformer 135 may be adapted to a predetermined frequency based on settings (adjustments) such as changing the set multiplier of the peripheral circuit and the material and degree of adhesion of the ferrite core (internal component of the transformer 135). The predetermined frequency is preferably a frequency corresponding to a high frequency. In this specification, unless otherwise specified, high frequency refers to a frequency band greater than 10 kHz, and low frequency refers to a frequency band below 10 kHz.

The switching circuit unit 140 switches the connection destinations of the output terminals Td and Te of the output waveform generating unit 130 (that is, the output terminals of the transformer 135) within the plurality of electrodes 40, thereby connecting a plurality of pairs of electrodes that generate output waveforms. control within the electrode 40 of. In this case, the switching circuit section 140 may control the pair of electrodes that generate the output waveform to change based on control information described later.

Note that the control system 100 shown in FIG. 4 is just an example, and may be changed as appropriate depending on the type of control information to be used (including the case of two or more types). For example, in the switching circuit section 140, the connection destinations of the output terminals Td and Te of the output waveform generating section 130 (that is, the output terminals of the transformer 135) may include other electrodes (not shown), and in this case, the output waveform The pair of electrodes that generate the oscillation may be switched in a time-sharing manner. Alternatively, two or more systems of drive circuit sections 120 and output waveform generation sections 130 may be provided. Furthermore, in the case of a configuration in which switching between the pair of electrodes is unnecessary, the switching circuit section 140 may be omitted. Further, the PWM signal may be directly applied to the drive circuit section 120 (without going through the control device 110) using an oscillator.

Next, further details of the information processing system 1 will be described with reference to FIG. 5 and subsequent figures.

FIG. 5 is an explanatory diagram illustrating an example of data related to control information, which is data stored in the storage unit 32 of the information processing device 3 according to the present embodiment. FIG. 6 is an explanatory diagram of the repetition information in FIG. 5. In FIG. 5 (the same applies to FIG. 12, etc., which will be described later), "***" indicates a state in which some information is stored, and "..." indicates a state in which similar information is repeatedly stored.

In the example shown in FIG. 5, the storage unit 32 includes association data 500 that associates objects and control information, and control information data 510 as data related to control information. Note that the method of dividing the association data 500 and the control information data 510 is for convenience of explanation, and in reality, similar data may be managed in other substantially similar ways. For example, the association data 500 and the control information data 510 may be integrated.

In the association data 500, an object name and a control information ID are associated with each object ID. The object ID is an identifier given to each object. The target object is a substance that can be applied to human skin, and is typically a substance that can be expected to have various effects such as beauty effects. The target object may be, for example, various components contained in cosmetics or the like. Alternatively, the target object may be various components contained in an external skin preparation. In addition, in the skin external preparation, the purpose of use of the substance carrier, such as pharmaceuticals and quasi-drugs, is arbitrary. Further, the target object may include a substance that is effective in promoting transdermal absorption of a quasi-drug that is metabolized in the liver and whose efficacy has not been fully exerted. In addition, the purpose of use of external preparations that are absorbed through the skin is arbitrary, and external preparations such as analgesics, anti-inflammatory agents, whitening agents, humectants, anti-wrinkle agents, anti-inflammatory agents, antibacterial agents, and antiviral drugs can be used. No matter the purpose of skin absorption.

The object name is the substance name of the object. Note that the substance name may be a formal name or an abbreviation. Further, since information on the object name is not directly used for control, it may be omitted.

The control information ID is an identifier given to each piece of control information. Note that one unit of control information may be for each control information ID.

The control information data 510 includes upper data 511 and lower data 512. Note that the division into upper data 511 and lower data 512 is for convenience of explanation, and in reality, similar data may be managed in other substantially similar ways. For example, the upper data 511 and the lower data 512 may be integrated.

In the upper data 511, mode configuration information, execution time ratio, reference execution time, and repetition information are associated with each control information ID.

The mode configuration information is information indicating in what order multiple output modes are executed. Note that in this embodiment, the mode configuration information associated with one control information ID includes two or more output modes, but in a modified example, mode configuration information that is associated with one control information ID includes only one output mode. Control information ID may also exist.

For example, in the example shown in FIG. 5, the mode configuration information associated with control information ID "001" indicates that output mode M3, output mode M4, and output mode M2, which will be described later, are executed in this order. .

The execution time ratio represents the ratio of the execution times of each output mode indicated by the mode configuration information to each other. Here, the ratio of the execution time of other output modes to the reference value "1" of the execution time of the first output mode is defined. Note that in other embodiments, information on the execution time itself may be used instead of the ratio of the execution time of each output mode.

For example, in the example shown in FIG. 5, the execution time ratio associated with control information ID "001" is the execution time of output mode M4 when the execution time of output mode M3, which will be described later, is set to a reference value "1". are the same "1", indicating that the execution time of output mode M2 is "1.2".

The reference execution time indicates the execution time related to the reference value. For example, in the example shown in FIG. 5, the execution time is 20 milliseconds; in this case, the execution time of output mode M3 is 20 milliseconds, and the execution time of output mode M4 is the same 20 milliseconds; The execution time of output mode M2 is 24 milliseconds.

The repetition information indicates whether each output mode indicated by the mode configuration information is repeatedly (periodically) executed. Here, as an example, "1" represents that it is repeatedly executed, and "0" represents that it is not repeatedly executed. Note that when the process is repeatedly executed, the number of repetitions and the manner of repetition (for example, the presence or absence of an interval, its length, etc.) may be specified.

For example, in the example shown in FIG. 5, the repetition information associated with the control information ID "001" is "1", and therefore, as shown in FIG. Mode M2 is repeatedly executed multiple times in this order.

In the lower data 512, each output mode is associated with a control parameter for outputting an output waveform related to the corresponding output mode. The control parameters are arbitrary, but in this embodiment, as an example, a first parameter indicating whether the output waveform is an AC waveform or a DC waveform, a second parameter related to frequency, and a third parameter related to amplitude (intensity) are used. include. Here, as an example, the value of the first parameter is "1" representing an AC waveform, "0" representing a DC waveform with positive polarity, and "2" representing a DC waveform with negative polarity. represents something. Note that when the output waveform is a DC waveform, the value of the second parameter may represent the frequency of pulse wave generation. Furthermore, in the case of a configuration in which the intensity of the output can be adjusted by the user, the value of the third parameter may function as a default value. Note that the third parameter may be a parameter related to voltage or duty indicating the output level.

For example, in the example shown in FIG. 5, the output mode M1 indicates that the value of the first parameter is "1" and the output waveform is an AC waveform. Further, the output mode M1 indicates that the value of the second parameter is "α1 (actually a specific numerical value)" and the frequency of the AC waveform is α1 [Hz]. Further, output mode M1 indicates that the value of the third parameter is "β1 (actually a specific numerical value)" and the amplitude of the AC waveform is β1 [V].

In this way, according to this embodiment, control information is associated with each object ID. Therefore, control information that can generate a suitable output waveform can be associated with the characteristics of the object for each object ID.

In particular, according to this embodiment, the control information associated with each object defines output waveform output (output via the paired electrodes 40 of the beauty device 4) in two or more output modes. That is, the control information represents a process that is executed continuously in time series by the beauty device 4, and a process using output waveforms having different characteristics (two or more types of predetermined processes). Thereby, it is possible to realize detailed processing suitable for each object.

Next, with reference to FIGS. 7 to 11, control information will be further explained along with some examples of output waveforms with different characteristics.

FIG. 7 is a diagram showing an example of an output waveform in output mode M1. In FIG. 7, the output waveform (time-series waveform) of the output mode M1 is shown, where the horizontal axis represents time and the vertical axis represents voltage value. Note that in FIG. 7, ΔT1 represents one cycle of the output waveform, and is determined according to the value of the second parameter (=α1) described above.

The output waveform of output mode M1 is an AC waveform and has multiple peak voltage values during a half cycle (ΔT/2). In this case, the plurality of peak voltage values include a first peak voltage value Vp1 and one or more second peak voltage values Vp2. The second peak voltage value Vp2 preferably occurs within a range of 5 to 25 times per half cycle, more preferably within a range of 10 to 20 times.

The first peak voltage value Vp1 is a peak voltage value that appears at the beginning of a half cycle, and the second peak voltage value Vp2 appears after the first peak voltage value Vp1 and is larger than the first peak voltage value Vp1. The size is small. As shown in FIG. 7, a plurality of second peak voltage values Vp2 may be generated in a manner that gradually decreases. The second peak voltage value Vp2 is preferably smaller than half the magnitude of the first peak voltage value Vp1.

Note that the output waveform as shown in FIG. 7 can be formed by setting the value of the second parameter (=α1) significantly lower than the above-mentioned predetermined frequency. In this embodiment, the above-mentioned predetermined frequency is 900 kHz or more (for example, 1 MHz), and in this case, the value of the second parameter (=α1) is preferably between 10 kHz and 500 kHz.

7A to 7C are diagrams showing other output waveforms that may be used instead of the output waveform of output mode M1 shown in FIG. 7. FIG. 7D is an enlarged view of section Q6 in FIG. 7C. The examples shown in FIGS. 7A and 7C differ from the output waveform shown in FIG. 7 mainly in that the second peak voltage value Vp2 does not exist. In this case, the voltage value of the output waveform for half a cycle changes from the first peak voltage value Vp1 in a manner that maintains a substantially constant value (substantially constant voltage value). In this case, the substantially constant value may be the same level as the second peak voltage value Vp2. Alternatively, the substantially constant value may be a level slightly smaller than the second peak voltage value Vp2, as shown in FIG. 7C. In this case, the peak waveform related to the first peak voltage value Vp1 has an effect similar to electroporation, and the subsequent electrical stimulation (in a section of approximately constant value) can be expected to have an effect of promoting penetration. Note that the term "substantially constant value" is a concept that allows an error that occurs in a relatively small sawtooth waveform as shown in FIG. 7D, for example, a concept that allows an error of 10% or less with respect to a constant value. Note that in FIG. 7D, B _Vp1 represents the magnitude (amplitude) of the first peak voltage value Vp1, and δ represents the fluctuation range of a substantially constant value. Note that although FIG. 7D is a diagram for explaining the substantially constant value in FIG. 7C, the same applies to FIG. 7A.

The example shown in FIG. 7B differs from the output waveform shown in FIG. 7 mainly in that the first peak voltage value Vp1 does not appear at the beginning of the half cycle but appears in the middle. In this case, the second peak voltage value Vp2 may appear at the beginning of the half cycle, as shown in FIG. 7B. Note that in the example shown in FIG. 7B, the first peak voltage value Vp1 appears near the middle of the half cycle, but it may appear significantly later (for example, at the end) (or significantly earlier) than near the middle. This also applies to the output waveforms shown in FIGS. 7A and 7C. That is, also in the output waveforms shown in FIGS. 7A and 7C, the first peak voltage value Vp1 does not necessarily need to appear at the beginning of the half cycle, but may appear in the middle or at the end of the half cycle.

Note that the various waveforms shown in FIGS. 7 to 7C may be substantially symmetrical waveforms in positive and negative directions, but may have a slight offset on the positive side or the negative side.

Here, in the various waveforms shown in FIGS. 7 to 7C, the duration of the first peak voltage value Vp1 (ΔT _Vp1 ) is preferably set relative to a half cycle (=ΔT/2) or within a half cycle. It is 1/5 or less of the remaining time (=ΔT/2−ΔT _Vp1 ) within (=ΔT/2). That is, ΔT _Vp1 ≦1/5×(ΔT/2−ΔT _Vp1 ). For example, in the example shown in FIG. 7, the duration of the first peak voltage value Vp1 (ΔT _Vp1 ) is preferably greater than the duration of the second peak voltage value Vp2 (=ΔT _Vp2 =ΔT/2−ΔT _Vp1 ). It is less than 1/5. Further, in the example shown in FIG. 7B, the duration of the first peak voltage value Vp1 (ΔT _Vp1 ) is preferably the sum of the durations of the two second peak voltage values Vp2 (=2×ΔT _Vp2 =ΔT/2 -ΔT _Vp1 ), it is 1/5 or less. Note that in these cases, the duration of the first peak voltage value Vp1 (ΔT _Vp1 ) may be measured as a period during which 80% or more of the magnitude of the first peak voltage value Vp1 is maintained.

FIG. 8 is a diagram showing an example of the output waveform in output mode M2. In FIG. 8, the output waveform (time-series waveform) of output mode M2 is shown, where the horizontal axis represents time and the vertical axis represents voltage value. Note that in FIG. 8, ΔT2 represents one cycle of the output waveform, and is determined according to the value of the second parameter (=α2) described above.

In output mode M2, a continuous waveform that periodically changes at least twice within one duration is generated. In this embodiment, the output waveform in output mode M2 is a pulsed DC waveform. Since such an output waveform has positive polarity, it can repel positive ions. Therefore, output mode M2 is suitable for positively charged objects (objects with a positive charge). Note that another output mode in which the value of Repulsion is "2" may have a waveform with inverted polarity as shown in FIG. Such an output mode is suitable for a negatively charged object (an object with a negative charge).

The frequency of the output waveform of output mode M2 (value α2 of the second parameter) is determined so that at least two pulsed DC waveforms are generated within one duration.

The output waveform of the output mode M2 may consist of a plurality of pulsed DC waveforms with the same amplitude, but the output waveforms of the other output modes may consist of one waveform with an amplitude (voltage value) significantly larger than the others. It may include more than one specific pulse. For example, FIG. 10 shows an example of the output waveform of another output mode in which only one specific pulse PL2 is included within one duration. A specific pulse increases the penetration effect of electrically charged objects (objects with positive or negative charges) into the skin by generating temporary pores in the skin (electroporation) through pulse stimulation. Has a function. In this case, the specific pulse is different from not only the amplitude but also the frequency with respect to pulses other than the specific pulse (hereinafter referred to as "mesoporation pulse" for distinction) in the output waveform of output mode M2. may also be different. Therefore, the control information related to the output mode including the mesoporation pulse may include each value of the second parameter and the third parameter related to the specific pulse. For example, for a mesoporation pulse, the value of the second parameter (=α2) may be set between 1.5kHz and 10kHz, and the value of the third parameter may be set such that the peak voltage value is less than 10V. May be set to . On the other hand, for a specific pulse, the value of the second parameter may be set between 2 Hz and 10 Hz, and the value of the third parameter may be set such that the peak voltage value is 10 V or more. Note that the polarity of the specific pulse may be the same as the polarity of the mesoporation pulse.

Note that the output waveform related to DC stimulation is not limited to the above-mentioned pulsed DC waveform, and for example, a mode that outputs a DC waveform of a constant value with a relatively long duration may be set as another output mode. .

By the way, in order to enhance the function of the mesoporation pulse, which has the effect of applying a high voltage and pushing the active ingredient (target object) into the deep layer with ions (mesoporation), it is necessary to temporarily apply a temporary effect to the skin by pulse stimulation. It may be useful to apply a mesoporation pulse immediately after application of a particular pulse that has the function of generating pores. This is because temporary pores tend to close quickly.

Therefore, the output waveform shown in FIG. 10 is suitable for objects that are difficult to be pushed into the deep layers of the skin with only the mesoporation pulse in output mode M2, since the mesoporation pulse is generated immediately after the application of a specific pulse. becomes. Furthermore, as will be described later, it has been found that the output waveforms shown in FIG. 7 (and FIGS. 7A to 7C) have similar or better effects depending on the target object (see FIGS. 16 and 17). (described later).

FIG. 11 is a diagram showing an example of an output waveform in output mode M3. In FIG. 11, the output waveform (time-series waveform) of output mode M3 is shown, where the horizontal axis represents time and the vertical axis represents voltage value. Note that in FIG. 11, ΔT3 represents one cycle of the output waveform, and is determined according to the value of the second parameter (=α3) described above.

Here, the output waveform as shown in FIG. 11 can be formed by making the value of the second parameter (=α3) related to the output mode M3 substantially coincide with the above-mentioned predetermined frequency. For example, when the predetermined frequency is around 900 kHz, by setting the value of the second parameter (=α3) around 900 kHz, an AC waveform close to a sine wave can be realized and the heating effect can be enhanced. Therefore, in this case, output mode M3 is suitable for a target object whose effect (effect related to the target object) is enhanced by heating the skin. Further, in this case, the value of the second parameter (=α1) related to the output mode M1 may be set between 10 kHz and 500 kHz.

In this way, output waveforms of various output modes can be continuously applied to the skin in various combinations. Therefore, it is possible to associate an optimal combination among various combinations of various output waveforms (output modes) for each object.

In this case, the optimal combination for each object may be found based on, for example, tests and experience. At this time, various characteristics or properties of the target object include, for example, (1) properties related to the solubility of the target object in a solvent, (2) properties related to electrification, and (3) molecular weight or its attributes. The setting may be based on at least one of the following.

For example, regarding (1), the properties (for example, the property of being water-soluble or fat-soluble) related to the solubility (same meaning of solubility) in a specific solvent (e.g., water or oil), , the temperature at which the external skin preparation is used and the pH (Potential Hydrogen) of the solution, such as whether it is water-soluble, fat-soluble (oil-soluble), or amphiphilic. . Regarding (2), for example, the number of charges may be 2, 1, 0, -1, or instead of or in addition to this, the positive or negative charge, or the category of no charge (not dissociated (charged) or amphoteric). electrolytes). It may also include characteristics related to the mode of dissociation in an aqueous solution and the strength of the acid or base. Regarding (3), the molecular weight itself may be used, or information indicating classification (attribute) such as low molecular weight or high molecular weight may be included.

For example, the polarity-related value (i.e., "0" or "2") of the above-mentioned first parameter values for one object takes into account the charging characteristics of the one object. may be set. In this case, a negative polarity DC waveform (ie, the value of the first parameter "2") may be set for a positively charged object. Further, a positive polarity DC waveform (ie, the value of the first parameter "0") may be set for a negatively charged object. Furthermore, for the one target object, each value of the second parameter and the third parameter is determined based on at least one of the property related to the solubility of the target object in a solvent, the molecular weight, or its attributes. It may also be set based on For example, for a polymer target, the value of the second parameter may be set between 30 kHz and 70 kHz. In this case, it becomes easier to realize an output waveform that causes large muscle contraction as an output waveform effective for penetration. Further, for a low-molecular object, the value of the second parameter may be set between 70 kHz and 200 kHz. In this case, as an output waveform effective for penetration, it is easy to realize an output waveform that causes small muscle contraction but has a combined effect with a warming sensation (a warming sensation due to a heating effect).

More specifically, the control information may be set in a manner as shown in FIG. 12, for example. FIG. 12 shows, as an example, control information corresponding to six components (objects): niacinamide, tranexamic acid, vitamin C derivative, collagen, hyaluronic acid, and retinol. In FIG. 12, an upper table 1200 shows various characteristics of six objects and part of the control information (part of the data corresponding to the higher-order data 511 shown in FIG. 5). For example, mode configuration information "M10+M20+M30" is associated with niacinamide. The mode configuration information "M10+M20+M30" indicates that output mode M10, output mode M20, and output mode M30 are executed in this order (or any other order may be used), and the same applies to the others. A table 1202 on the lower side of FIG. 12 shows a part of the control information (a part of the data corresponding to the lower-order data 512 shown in FIG. 5). Note that the numerical values of the second parameters shown in FIG. 12 are merely examples, and may be adapted according to tests (for example, test results described later with reference to FIGS. 16 to 17H).

In the example shown in FIG. 12, even if the output modes M20, M21, and M30 have the same AC waveform, the frequencies are different, so that different effects can be expected from each other. For example, in the output mode M21, as mentioned above, a relatively high penetration effect can be expected due to relatively large muscle contraction, and although the muscle contraction is small, it can be expected to have a combined effect with a warming sensation (warming sensation due to the heating effect). can. Furthermore, in the output mode M30, as shown in the value of the second parameter, the frequency of the output waveform is relatively high, and a high heating effect can be expected.

Next, an example of the operation of the information processing system 1 described above will be described with reference to FIG. 13.

FIG. 13 is a timing chart schematically showing an example of the operation of the information processing system 1.

First, the user turns on the power of his or her beauty device 4 and establishes a connection with the user terminal 2 (step S1300). Note that the user may have already performed pairing with the user terminal 2 as the initial settings of the beauty device 4.

Next, the user terminal 2 identifies or estimates one or more objects attached to the user's skin (step S1302). For example, the user inputs information into the user terminal 2 that allows him to specify the cosmetics to be applied to his skin this time. In this case, the user terminal 2 can identify or estimate one or more objects based on user input. Note that if the cosmetics used are the same each time (same as the previous time), the input may be omitted, or the same input as the last time may be made. Furthermore, the beauty device 4 may include a measuring section (not shown) in the operating section 4a, and in this case, the user terminal 2 can measure the target contained in the cosmetics based on the measurement results that can be obtained from the beauty device 4. Can identify things. After identifying the target object, the user terminal 2 transmits the identification result to the information processing device 3 (step S1304). In addition, in a modified example, instead of the user terminal 2, the beauty device 4 may directly transmit the identification result to the information processing device 3.

Upon acquiring the target object identification result from the user terminal 2 (step S1306), the control unit 33 of the information processing device 3 extracts control information corresponding to the target object from the storage unit 32. For example, the control unit 33 specifies the control information ID associated with the target object ID based on the target object ID corresponding to the target object, and based on the specified control information ID, the control unit 33 specifies the control information ID corresponding to the target object ID. Extract (step S1308). Then, the control unit 33 transmits the extracted control information to the user terminal 2 (step S1310). In this way, when the control unit 33 acquires the object identification result from the user terminal 2 that is the request source (step S1306), it transmits the control information corresponding to the object to the user terminal 2.

Upon acquiring the control information from the information processing device 3 (step S1312), the user terminal 2 transmits it to the beauty device 4 (step S1314).

Upon acquiring the control information, the beauty device 4 operates based on the control information (step S1316). For example, in the example shown in FIG. 4 described above, the control device 110 generates the control signal CT1 etc. according to the control information, so that the output waveform according to the control information can be transmitted to the user via the plurality of electrodes 40. apply to the skin. Note that the beauty device 4 may perform preprocessing as appropriate before generating an output waveform according to the control information. In this case, the preprocessing may also be specified by the control information. This is not limited to pre-processing, but also applies to post-processing and intermediate processing (for example, processing that may be executed during repetition intervals).

In this way, according to the example shown in FIG. 13, when the control unit 33 acquires the target object identification result from the user terminal 2 that is the request source (step S1306), the control unit 33 performs the process based on the control information corresponding to the target object. , controls the beauty device 4 via the user terminal 2 (steps S1310 to S1316). In addition, in the modified example, when the control unit 33 acquires the target object identification result from the user terminal 2 that is the request source (step S1306), the control unit 33 performs the identification without going through the user terminal 2 based on the control information corresponding to the target object. The beauty device 4 may also be directly controlled.

Next, other embodiments will be described with reference to FIG. 14 and subsequent figures.

FIG. 14 is a diagram showing data according to another embodiment that can be used in place of the data shown in FIG. 5 (data related to control information).

In the example shown in FIG. 14, characteristics, object ID, object name, and control information ID are associated with each object group ID.

The object group ID is an identifier given to each group when a plurality of objects are divided into a plurality of groups. The plurality of objects are preferably grouped in a manner that includes a plurality of objects having common characteristics. In this case, the common characteristics include at least one of the above-mentioned (1) properties related to the solubility of the target object in the solvent, (2) properties related to electrification, and (3) molecular weight or its attributes. It may have such characteristics.

The characteristic associated with the object group ID may be a characteristic that all objects belonging to the group associated with the corresponding object group ID have in common. In the example shown in FIG. 14, the characteristics associated with the object group ID are (1) the property related to the ease of solubility of the object in a solvent is "water-soluble", and (2) the property related to charging is " (3) The molecular weight or its attributes are "low molecular."

Incidentally, in products such as cosmetics, a single product may contain multiple objects. In this case, when the user applies a plurality of objects related to one product to the skin and uses the beauty device 4, the control information used to control the beauty device 4 includes at least one of the plurality of objects. The control information may be related to one target object. For example, when control information is associated with a part of a plurality of objects, the control information associated with the part may be used. Alternatively, control information associated with the object with the largest content (the object listed at the top of the ingredient list) among the plurality of objects may be used.

Alternatively, if one product includes multiple objects, or if multiple products including different objects are used, multiple pieces of control information may be used at the same time. That is, based on a plurality of pieces of control information, outputs of a plurality of output waveforms corresponding to each piece of control information may be applied to the user's skin via the beauty device 4.

FIG. 15 is an explanatory diagram of a specific example of control information related to the example shown in FIG. 14. In the example shown in FIG. 15, like the example shown in FIG. 14, control information is associated with each object group. Note that in FIG. 15, the control information is indicated by a name indicating each output mode. In this case, "MSMP" corresponds to the output mode M1 shown in FIG. 7 (or the output mode related to the output waveforms of FIGS. 7A to 7C), and "RF" corresponds to the output mode M30 shown in FIG. 12. However, "repulsion (+)" corresponds to the output mode M10 shown in FIG. 12, "constant voltage (+)" corresponds to the positive constant voltage DC waveform, and "repulsion (-)" , corresponds to the output mode M11 shown in FIG. 12, and "constant voltage (-)" corresponds to a DC waveform of a constant voltage on the negative side. Further, "repulsion (+ or -)" may include either one of the above-mentioned "repulsion (+)" and "repulsion (-)" or a combination thereof. Similarly, the "constant voltage (+ or -)" may include any one of the above-mentioned "constant voltage (+)" and "constant voltage (-)" or a combination thereof. Further, "strong RF" may correspond to an output mode in which the value of the third parameter is larger than the output mode M30 shown in FIG. 12. Further, "EMS (high frequency)" may correspond to output mode M20 or M21 shown in FIG. 12.

Here, with respect to the target group shown in FIG. 15, some examples of useful ingredients of skin external preparations suitable for penetration will be listed.

At pH in the weakly acidic to neutral range <compounds that are positively charged or have a tendency to be positively charged in aqueous solution, or are ampholyte electrolytes>
Compounds that are positively charged or have a tendency to be positively charged include, but are not limited to, tranexamic acid, tranexamic acid derivatives such as cetyl tranexamic acid hydrochloride, and niacinamide, which are ingredients known to have whitening effects. do not have. In addition, pyridoxine hydrochloride and its derivatives, which are effective for acne and rough skin, benzalkonium chloride, which is used for sterilization and disinfection, and peptides with isoelectric points on the alkaline side, which are said to be effective in improving wrinkles, such as Examples include peptides such as palmitoyl tripeptide-5, acetyl hexapeptide-8, diacetate dipeptide diaminobutyroylbenzylamide, and derivatives thereof. Furthermore, allantoin, ardioxa, carnitine HCl, basic amino acids such as lysine, arginine, histidine, tryptophan, ornithine, etc., as well as ergothioneine, and urea as a moisturizing agent are listed as examples, but at a pH around weakly acidic to weakly alkaline. Any substance may be used as long as it has a functional group that is positively charged or polarized (it only needs to be cationic even if the amount of charge is minute), and is not limited to these compounds.
In addition, ampholytes with functional groups that are acidic to slightly alkaline and positively charged or polarized include tranexamic acid, which is said to have a whitening effect, glycine, proline, alanine, serine, acetylhydroxyproline, ε-aminocaproic acid, Examples include neutral amino acids such as γ-aminobutyric acid and derivatives thereof, trimethylglycine, and the like.
<Compound group that is negatively charged or tends to be negatively charged in aqueous solution>
In addition to 4-methoxysalicylic acid potassium salt and disodium adenosine monophosphate, which are recognized to be effective as skin whitening agents, ascorbic acid, L-ascorbic acid 2-glucoside, sodium L-ascorbyl phosphate, and magnesium L-ascorbyl phosphate. , L-ascorbic acid disodium sulfate, ascorbic acid and derivatives thereof such as trisodium ascorbyl palmitate phosphate, sodium dl-α tocopheryl phosphate, and the like. Further examples include zinc paraphenolsulfonate, salicylic acid and its sodium salt, and acidic amino acids such as sodium lactate, sodium L- or DL-pyrrolidonecarboxylate solution, sodium L-glutamate, and sodium L-aspartate. In addition, glycyrrhizic acid and its salts such as glycyrrhizic acid, dipotassium glycyrrhizinate, and ammonium glycyrrhizinate, which are said to have the effect of calming inflammation, sodium guaiazulene sulfonate, lysine Na dilauroylglutamate, etc., are used at a pH around weakly acidic to weakly alkaline. Any substance may be used as long as it has a functional group that is electrically charged or polarized (even if the amount of charge is small, it is sufficient as long as it is anionic), and is not limited to the above.
<Compounds that are hardly charged in aqueous solution>
Kojic acid, arbutin, hydroquinone, 4-(1-phenylethyl)-1,3-benzenediol, 4-n-butylresorcinol, 5,5'-dipropyl-biphenyl-2,2', which are said to have whitening effects. - Ascorbic acid derivatives such as diol, ellagic acid, 3-O-ethyl ascorbic acid, 3-glyceryl ascorbic acid, bisglyceryl ascorbic acid, hexyl 3-glyceryl ascorbic acid, myristyl 3-glyceryl ascorbic acid, 3-laurylglyceryl ascorbic acid, D-pantothenyl alcohol, cholecalciferol, 3-o-cymen-5-ol (isopropylmethylphenol), sugars such as xylose, sorbitol, mannitol, and polyols such as butylene glycol, hexylene glycol, pentylene glycol, glycerin and terpenes such as hinokitiol. In addition, the poorly soluble substances fullerene, oryzanol, ceramide EOP, ceramide EOS, ceramide NG, caprooyl sphingosine, ceramide NP, N-stearoyl phytosphingosine, N-stearoyl dihydrosphingosine, ceramide AG, ceramide AP, hydroxystearyl phytosphingosine , ceramide 6II, and phytosphingosine are also listed as useful ingredients, regardless of whether they are encapsulated in liposomes or not. Further examples include extracts obtained from plants and animals that exhibit usefulness, culture solutions of stem cells, etc., and culture supernatants.

In addition, flavonoids include isoflavones, licorice root extract, licorice flavonoids, and licorice flavonoids as other beauty ingredients that are water-soluble or dissolve in coexistence with a water-soluble solvent, and furthermore as beauty ingredients that dissolve as micelles in the aqueous phase. It can be mentioned, but it is not limited to this. Extracts include Chamomilla ET, Clara root extract, Oriental japonica extract, carrot and its root extract, soybean extract and soybean seed extract, tea leaf extract, Galactomyces culture solution, Rice Power No. 11 (rice extract No. 11), astaxanthin liquid, red algae extract, placenta extract and placenta extracts (1) to (5), and water-soluble and hydrolyzed placenta extracts.
<Lipids and oil-soluble substances>
Retinol and its derivatives such as squalane, linoleic acid, ascorbyl tetra-2-hexyldecanoate, ascorbyl dipalmitate, retinol, retinol acetate, retinol palmitate, hydrogenated retinol, retinol linoleate, tocopherol nicotinate, dl-α-tocopherol, d - Tocopherol and its derivatives such as δ-tocopherol, natural vitamin E, DL-α-tocopherol acetate, stearyl glycyrrhetinate, estradiol, ethinyl estradiol, astaxanthin, rice germ oil, phospholipids such as sphingomyelin, synthetic and vegetable squalane , guaiazulene and guaiazulene sulfonic acid ester, fatty acid esters of ascorbic acid such as ascorbyl stearate and ascorbyl palmitate, di(phytosteryl/octyldodecyl) lauroylglutamate, and oil-soluble placenta.
<Compounds and polymer compounds with relatively high molecular weight>
Human recombinant oligopeptide-1, palmitoyl hexapeptides including palmitoyl hexapeptide-4, palmitoyl pentapeptides, hydrolyzed collagen and its derivatives, hyaluronic acid, sodium hyaluronate, acetylated sodium hyaluronate, etc. Hyaluronic acid and its derivatives Examples include derivatives, white fungus polysaccharides, alcaligenes-producing polysaccharides, and polyquaterniums.

Next, test results regarding some specific objects will be described with reference to FIGS. 16 to 17H.

FIG. 16 is a diagram showing the test results when a specific output waveform was applied to a specific target "magnesium ascorbyl phosphate." Specifically, FIG. 16 is a diagram comparing the permeation effects of active ingredients with various output waveforms. In FIG. 16, the vertical axis shows the absorption amount in the stratum corneum (in FIG. 16, it is expressed as "permeation amount in the stratum corneum, relative value"), and the horizontal axis shows various test conditions C1 to C5. The amount of absorption in the stratum corneum under each of conditions C1 to C5 is shown. Note that the absorption amount in the stratum corneum on the vertical axis is shown as a relative value based on the test condition C1 (hereinafter, the same applies to FIG. 17, etc.). Test condition C1 corresponds to a condition in which no output waveform is generated from beauty device 4 (hereinafter also referred to as "output non-use condition"). Further, test conditions C2 to C5 are conditions for using the beauty device 4, test condition C2 corresponds to a condition in which only the output waveform (see FIG. 11) by output mode M3 is provided, and test condition C3 is Test condition C4 corresponds to a condition in which only the output waveform of output mode M2 (the positive output waveform shown in FIG. 8) is given, and the test condition C4 corresponds to the condition in which only the output waveform of the other output mode (the negative output waveform shown in FIG. 9) is given. corresponds to the condition that only is given. Further, test condition C5 corresponds to a condition in which only the output waveform of output mode M1 as shown in FIG. 7 is provided.

This test was performed according to the following steps.
1) First, to confirm skin homeostasis, after washing the forearm, acclimatize for 15 minutes, measure the amount of water evaporation at the application site (5 locations), and confirm that there are no large fluctuations in the value or scars. did.
2) Next, quantitative measurements were performed from the facial treatment as follows.
2-1: Drop the sample onto the forearm.
2-2: After the treatment in 2-1, use the sample in a circular motion at a speed of 1 rotation per second for 1.5 minutes from above the sample. Note that under the output non-use condition, the same operation is realized using the beauty device 4 with the power turned off (that is, the beauty device 4 in a state where no output waveform is generated).
2-3: After the treatment in 2-2, the remaining sample was wiped off with cotton, and the skin surface was wiped with cotton soaked in 50% ethanol solution for washing.
2-4: After the treatment in 2-3, peel off the stratum corneum at the application site with adhesive tape (keratin checker commercially available under the trade name "D-Squame (registered trademark)"), The amount of VCPMg (L-ascorbyl magnesium phosphate) contained in each layer is determined.

Note that in this test, the electrical influence of the beauty device 4 was taken into consideration and the test was performed from test condition C1.

As shown in FIG. 16, it was found that the output waveform of output mode M1 shown in FIG. 7 was more advantageous than the output waveforms of other modes in penetrating magnesium ascorbyl phosphate into the stratum corneum.

From such tests, magnesium ascorbyl phosphate or a substance having substantially similar properties (for example, the above-mentioned compounds that are negatively charged in an aqueous solution at a pH around weakly acidic to weakly alkaline) It can be seen that when the target object is a substance listed in (1), control information having mode configuration information including the output mode M1 is preferable. In this way, by testing each component, it is possible to determine which control information is valid, and it is possible to associate the control information ID related to the valid control information with the target object.

FIG. 16A is a table showing other test results regarding the specific target "magnesium ascorbyl phosphate."

In FIG. 16A, the test results under various test conditions C24 to C31 are evaluated based on the test results under test condition C1, which is the output non-use condition. The test results are evaluated based on the amount of absorption within the stratum corneum, which is the total value of the first layer of the stratum corneum, the total value of the second to fifth layers, the total value of the sixth to tenth layers, and the total value of the second layer. The total value of the 10th layer from the 1st layer is measured.

The test results are divided into test groups G161 to G165 and compared. In test groups G161, G163 to G165, the pH of the solution was 7.5, the concentration was 1.0%, and the usage time was 90 seconds. The test groups G161, G163 to G165 have different numbers of N, which are 4, 10, 3, and 14, respectively. In test group G162, the pH of the solution was 7.5, the concentration was 1.0%, the usage time was 60 seconds, and the number of N was 10.

In test group G161, the output waveform according to test condition C24 is AC stimulation with a frequency of 70 kHz, and the current value is set to be relatively high. The output waveform according to test condition C25 is an alternating current stimulation with a frequency of 70 kHz, and the current value is set to be relatively low (specifically, half of test condition C24). The output waveform according to test condition C26 is an alternating current stimulus with a frequency of 50 kHz, and the output waveform according to test condition C27 is an alternating current stimulus with a frequency of 156 kHz. From the test results of test group G161, it was found that magnesium ascorbyl phosphate or a substance having substantially similar properties (for example, as described above, at a pH around weakly acidic to weakly alkaline, it is charged to - in an aqueous solution) It can be seen that it is particularly effective against the substances listed in the compound group> in the frequency bands of 70 kHz and 156 kHz. Further, when comparing the current amount of 70 kHz (C24, C25), it can be seen that the higher the current of C24, the higher the amount of penetration. Further, when comparing the frequencies (C25, C26, C27), it can be seen that the lower frequency of 50 kHz (C26) has a larger amount of penetration. Note that the waveforms of AC stimulation with a frequency of 70 kHz and a frequency of 156 kHz have the form shown in FIG. 7 (waveforms related to output mode M1), but the same waveforms can be obtained even if the waveforms have the forms of FIGS. 7A to 7C. can be expected.

In test group G162, the output waveform according to test condition C28 is an AC stimulation with a frequency of 130 kHz, and the output waveform according to test condition C29 is an AC stimulation with a frequency of 130 kHz and a negative DC stimulation (frequency according to the second parameter = 10 kHz). ). From the test results of test group G162, it was found that magnesium ascorbyl phosphate or a substance having substantially similar properties (for example, as mentioned above, at a pH around weakly acidic to weakly alkaline, it is charged <- in an aqueous solution). It can be seen that these output waveforms are effective for substances listed in the compound group>.

The output waveform according to test condition C30 in test group G163 is negative direct current stimulation (frequency according to second parameter = 1.5 kHz). Further, the output waveform according to test condition C31 in test group G164 is electroporation of a 20 V rectangular pulse wave (pulse width = 120 usec). Further, the output waveform according to the test condition C33 in the test group G165 is a negative direct current stimulation (frequency according to the second parameter = 10 kHz). From these results, it can be seen that higher frequencies are more effective in negative direct current stimulation.

From such tests, magnesium ascorbyl phosphate or a substance having substantially similar properties (for example, the above-mentioned compounds that are negatively charged in an aqueous solution at a pH around weakly acidic to weakly alkaline) (substances listed in ) is the target object, output waveforms such as output mode M20 and output mode M21 described above with reference to FIG. It can be seen that the substance can be effectively penetrated into the skin. Therefore, for example, for magnesium ascorbyl phosphate or a substance having substantially similar properties thereto, control information having mode configuration information including at least one of output mode M20 and output mode M21 is associated. It's okay to be hit. In this way, by testing each component, it is possible to determine which control information is valid, and it is possible to associate the control information ID related to the valid control information with the target object.

In addition, control information associated with magnesium ascorbyl phosphate or a substance with substantially similar properties (for example, a substance with low molecular weight, water-soluble, or easily negatively charged) has the following characteristics. It's fine. That is, the value of the second parameter (=α1) is preferably a frequency of 10 kHz to 500 kHz, for example, with respect to the output mode M1 shown in FIG. 7 (or the output mode according to the output waveforms of FIGS. 7A to 7C). The frequency is more preferably from 50 kHz to 160 kHz, and most preferably around 70 kHz. Furthermore, when combining with other output waveforms, it is desirable to apply 40% or more of 10 kHz to 500 kHz (preferably 10 kHz to 200 kHz) within a predetermined period. At this time, 10 kHz to 500 kHz (preferably 10 kHz to 200 kHz) is preferably continuously applied for 1 second or more. This is because, although the effect can be confirmed even when the application is repeated intermittently for less than 1 second, a higher effect is obtained when the application is applied continuously for 1 second or more even if the total time is the same.

FIG. 17 is a diagram showing test results when a specific output waveform is applied to a specific target "niacinamide (vitamin B3)." In FIG. 17, test conditions C1 to C5 are as described above with reference to FIG. Test condition C6 corresponds to electroporation. In FIG. 17, only the sample is different, but in the case of niacinamide, the time in 2-2 of the above test procedure was 60 seconds.

As shown in FIG. 17, it was found that the output waveform of output mode M1 shown in FIG. 7 was more advantageous than the output waveforms of other modes in penetrating niacinamide into the stratum corneum. This is because the output waveform of output mode M1 shown in FIG. 7 has elements of electroporation and high frequency rather than just electroporation and high frequency (for example, the output waveform of output mode M3 (see FIG. 11)) itself. It is expected that there will be.

From such tests, it has been found that when the target object is niacinamide or a substance having substantially similar properties thereto, control information having mode configuration information including the output mode M1 is preferable. In this way, by testing each component, it is possible to determine which control information is valid, and it is possible to associate the control information ID related to the valid control information with the target object.

FIG. 17A is a table showing other test results regarding the specific target "tranexamic acid". FIG. 17A shows the test results in the same manner as FIG. 16A described above.

The test results are divided into test groups G171, G172, and G173 and compared. In test groups G171 and G172, the pH of the solution was 7.5, the concentration was 2.0%, and the usage time was 60 seconds. Test groups G171 and G172 have different numbers of N, which are 10 and 3, respectively. In test group G173, the pH of the solution was 7.6, the concentration was 2.0%, the usage time was 180 seconds, and the number of N was 3.

In test group G171, the output waveform according to test condition C45 is an AC stimulation with a frequency of 130 kHz, and the output waveform according to test condition C46 is an AC stimulation with a frequency of 130 kHz and a positive DC stimulation (frequency according to the second parameter = 10 kHz). ). From the test results of test group G171, it was found that tranexamic acid or a substance having substantially similar properties (for example, the above-mentioned compound group that is positively charged in an aqueous solution at a pH around weakly acidic to weakly alkaline) It can be seen that these output waveforms are effective for the substances listed in >. Note that the waveform of the alternating current stimulation with a frequency of 130 kHz has the form shown in FIG. 7 (the waveform according to output mode M1), but it can be expected that the same result can be obtained even with the waveforms of the forms shown in FIGS. 7A to 7C. .

In test group G172, the output waveform according to test condition C47 is an AC stimulus with a frequency of 1 MHz, and the output waveform according to test condition C48 is a positive DC stimulus (frequency according to the second parameter = 10 kHz), and the test condition The output waveform related to C49 is a negative DC stimulus (frequency related to the second parameter = 10 kHz), and the output waveform related to test condition C50 is an AC stimulus with a frequency of 70 kHz. The output waveform according to test condition C51 is 20V electroporation.

In test group G173, the output waveform according to test condition C55 is an AC stimulation with a frequency of 180 kHz, and the output waveform according to test condition C56 is an AC stimulation with a frequency of 130 kHz.

From such tests, it was found that the output waveform of the output mode M20 described above, and the combination of the output waveform of the output mode M20 and the output waveform of the positive DC stimulation, have tranexamic acid or properties substantially similar thereto. It can be seen that the substances possessing this substance can be effectively penetrated into the skin. Therefore, for example, for tranexamic acid or a substance having substantially similar properties, among the output mode M20 and the combination of the output waveform like output mode M20 and the output waveform of positive DC stimulation, Control information having mode configuration information including at least one of the above may be associated with the control information. In this way, by testing each component, it is possible to determine which control information is valid, and it is possible to associate the control information ID related to the valid control information with the target object.

In addition, from the results of test group G173, in FIG. 15, control information associated with tranexamic acid or a substance with substantially similar properties (for example, a low-molecular, water-soluble, substance that is easily charged positively) may have the following characteristics: That is, the value of the second parameter (=α1) is preferably a frequency of 10 kHz to 500 kHz, for example, with respect to the output mode M1 shown in FIG. 7 (or the output mode according to the output waveforms of FIGS. 7A to 7C). The frequency is more preferably 10 kHz to 200 kHz, even more preferably 50 kHz to 180 kHz, and most preferably around 130 kHz. In addition, when combining, it is desirable to apply 40% or more of 10 kHz to 500 kHz (preferably 10 kHz to 200 kHz) within a predetermined period. At this time, 10 kHz to 500 kHz (preferably 10 kHz to 200 kHz) is preferably continuously applied for 1 second or more. This is because even if the total time was the same, a higher effect was obtained when the application was applied continuously for more than 1 second than when it was applied intermittently for less than 1 second. It is.

FIG. 17B is a table showing other test results for the specific target "niacinamide." FIG. 17B shows the test results in the same manner as FIG. 16A described above.

The test results are divided into test groups G181 to G185 and compared. For test groups G181 to G185, the pH of the solution was 7.6, the concentration was 2.0%, and the usage time was 60 seconds. Among the test groups G181 to G185, only the test group G184 differs in that the number of N=6, and all the others have the number of N=4.

In test group G181, the output waveform according to test condition C64 is AC stimulation with a frequency of 1 MHz, and the output waveform according to test condition C65 is 20V electroporation. From the test results of test group G181, it was found that niacinamide or a substance having substantially similar properties (for example, the above-mentioned compound group that is positively charged in an aqueous solution at a pH around weakly acidic to weakly alkaline) It can be seen that alternating current stimulation with a frequency of 1 MHz is effective for substances listed in >.

Further, the output waveform according to test condition C66 in test group G182 is a negative DC stimulus (frequency according to the second parameter = 10 kHz), and the output waveform according to test condition C68 in test group G183 is a positive DC stimulus ( The frequency related to the second parameter = 10 kHz).

Furthermore, in test group G184, the output waveform according to test condition C69 is an AC stimulation with a frequency of 70 kHz, and the output waveform according to test condition C70 is an AC stimulation with a frequency of 130 kHz. From the test results of test group G184, it was found that niacinamide or a substance having substantially similar properties (for example, the above-mentioned compound group that is positively charged in an aqueous solution at a pH around weakly acidic to weakly alkaline) It can be seen that alternating current stimulation with a frequency of 130 kHz is effective for substances listed in >. Note that the waveform of the alternating current stimulation with a frequency of 130 kHz has the form shown in FIG. 7 (the waveform according to output mode M1), but it can be expected that the same result can be obtained even with the waveforms of the forms shown in FIGS. 7A to 7C. .

Further, in test group G185, the output waveform according to test condition C72 is an AC stimulus with a frequency of 130 kHz and a rectangular waveform, and the output waveform according to test condition C73 is an AC stimulus with a frequency of 130 kHz and a waveform shown in FIG. (waveform related to output mode M1). From the test results of test group G185, it was found that niacinamide or a substance having substantially similar properties (for example, the above-mentioned compound group that is positively charged in an aqueous solution at a pH around weakly acidic to weakly alkaline) It can be seen that AC stimulation with a frequency of 130 kHz is effective for the substances listed in > 130 kHz regardless of the waveform, and that the waveform of the form shown in FIG. 7 is particularly effective. Note that the effects related to test condition C73 can be expected to be similarly obtained even with waveforms in the form of FIGS. 7A to 7C.

From such tests, niacinamide or substances having substantially similar properties (for example, listed in the group of compounds that are positively charged in an aqueous solution at a pH around weakly acidic to weakly alkaline as mentioned above) In particular, when the object is a substance that has been treated with niacinamide or a substance having substantially similar properties, output waveforms such as output modes M20 and M30 described above with reference to FIG. It can be seen that it can be effectively penetrated into the skin. Therefore, for example, control information having mode configuration information including at least one of output modes M20 and M30 may be associated with niacinamide or a substance having substantially similar properties thereto. In this way, by testing each component, it is possible to determine which control information is valid, and it is possible to associate the control information ID related to the valid control information with the target object.

FIG. 17C is a table showing other test results regarding the specific target "kojic acid". FIG. 17C shows the results of a test in the same manner as in FIG. 16A described above, except that the substance was changed to kojic acid.

The pH of the solution was 6.5, the concentration was 1.0%, the usage time was 60 seconds, and the number of N was 3. The output waveform according to test condition C80 is an alternating current stimulus with a frequency of 1 kHz, the output waveform according to test condition C81 is an alternating current stimulus with a frequency of 130 kHz, and the output waveform according to test condition C82 is an alternating current stimulus with a frequency of 10 Hz. , the output waveform according to test condition C83 is an alternating current stimulation with a frequency of 90 kHz.

From these tests, it was confirmed that kojic acid or a substance with similar properties (e.g., low molecular weight, water-soluble, hardly charged in an aqueous solution) has a penetrating effect even outside the high frequency band.

Therefore, the control information associated with kojic acid or a substance with properties similar to this (for example, a substance with a low molecular weight, water-soluble, and hardly charged in an aqueous solution) may have the following characteristics. The value of the second parameter (=α1) is, for example, for the output mode M1 shown in FIG. 7 (or the output mode according to the output waveforms of FIGS. 7A to 7C), where AC stimulation of 200 kHz or less is suitable, preferably 10 Hz. ~130kHz is preferred.

FIG. 17D is a table showing other test results regarding the specific target "arbutin". FIG. 17D shows the results when the same test as in FIG. 16A described above was conducted by changing the substance to arbutin.

The output waveform according to test condition C100 is an AC stimulus with a frequency of 1 MHz, the output waveform according to test condition C101 is a positive DC stimulus, and the output waveform according to test condition C102 is a negative DC stimulus. Further, the output waveform according to test condition C103 is an alternating current stimulus with a frequency of 70 kHz, and the output waveform according to test condition C104 is an alternating current stimulus with a frequency of 10 Hz.

From these tests, in the case of arbutin, better penetration effects were confirmed under test conditions C100 and C101 compared to test conditions C1. Furthermore, it was confirmed that a better penetration effect could be obtained by alternating current stimulation at 200 kHz or less than by negative direct current stimulation as in test condition C102.

FIG. 17E is a table showing other test results regarding the specific target "phenylethylresorcinol." FIG. 17E shows the results when the same test as in FIG. 16A described above was conducted by changing the substance to phenylethylresorcinol.

The output waveform according to test condition C110 is an alternating current stimulus with a frequency of 130 kHz, the output waveform according to test condition C111 is an alternating current stimulus with a frequency of 1 kHz, and the output waveform according to test condition C112 is an alternating current stimulus with a frequency of 10 Hz. . The output waveform according to test condition C113 is an alternating current stimulation with a frequency of 40 kHz.

From these tests, it was confirmed that in the case of phenylethylresorcinol, a good penetration effect can be obtained by alternating current stimulation at 200 kHz or less, as in the case of arbutin.

FIG. 17F is a table showing other test results regarding the specific target "hydrolyzed collagen." FIG. 17F shows the results of the same test as in FIG. 16A described above, except for using hydrolyzed collagen as the substance. However, in this test, for 2-4 mentioned above, after the treatment in 2-3, the stratum corneum of the applied area was covered with adhesive tape (a commercially available horn checker under the trade name "D-Squame (registered trademark)"). ), and the amount of hydrolyzed collagen contained in the 1st to 10th layers of the stratum corneum was quantified.

The pH of the solution was 6.3, the concentration was 10.0%, the usage time was 300 seconds, and the number of N was 2. The output waveform according to test condition C90 is an alternating current stimulus with a frequency of 70 kHz, and the output waveform according to test condition C91 is a combination with switching between an alternating current stimulus with a frequency of 30 kHz and an alternating current stimulus with a frequency of 70 kHz (i.e., alternate application). be.

From these tests, it was confirmed that hydrolyzed collagen or substances with properties similar to this (e.g., polymer compounds) had a penetrating effect even in frequencies other than the high frequency band.

Therefore, the control information associated with hydrolyzed collagen or a substance with similar properties (for example, a polymer compound) may have the following characteristics. For example, the value of the second parameter (=α1) is preferably 30 kHz to 100 kHz, more preferably around 70 kHz, with respect to the output mode M1 shown in FIG. 7 (or the output mode according to the output waveforms of FIGS. 7A to 7C). It is. It is also preferable to apply 30 to 100 kHz alternating current stimulation and direct current stimulation within a predetermined period. It is also preferable to apply different frequency bands of 30 to 100 kHz in combination within a predetermined period.

FIG. 17G is a table showing other test results regarding the specific target "collagen peptide." FIG. 17G shows the results when the same test as in FIG. 17F described above was conducted by changing the substance to collagen peptide.

The output waveform according to test condition C130 is an alternating current stimulus with a frequency of 1 MHz, the output waveform according to test condition C131 is an alternating current stimulus with a frequency of 70 kHz, and the output waveform according to test condition C132 is an alternating current stimulus with a frequency of 3 MHz and an alternating current stimulus with a frequency of 70 kHz. A combination involving alternating current stimulation (i.e., alternating application). Further, the output waveform according to test condition C133 is an alternating current stimulus with a frequency of 70 kHz, and the output waveform according to test condition C134 is a combination with switching between a 30 kHz alternating current stimulus and a 70 kHz alternating current stimulus (i.e., alternate application). be. The difference between test condition C131 and test condition C133 is that the former has a usage time of 90 seconds and the number of N = 3, whereas the latter has a usage time of 300 seconds and the number of N = 2. Note that test conditions C130 to C132 have a usage time of 90 seconds and a number of N = 3, and test conditions C134 have a usage time of 300 seconds and a number of N = 2.

Regarding collagen peptides, as shown in FIG. 17G, compared to test condition C1, only test condition C130, only AC stimulation of 100 kHz or less (for example, AC stimulation of 70 kHz) such as test conditions C131 and C133, and test condition C132 It was found that a combination of an alternating current stimulus of 100 kHz or less and a high frequency (e.g. 3 MHz), and a combination of an alternating current stimulus of 100 kHz or less and another alternating current stimulus of 100 kHz or less (e.g. 30 kHz and 70 kHz) as in test condition C134 are suitable. . Furthermore, it has been found that AC stimulation of 100 kHz or less and stimulation by a combination of high frequency (for example, 3 MHz) AC stimulation and AC stimulation of 100 kHz or less are suitable.

Note that it can also be expected to have a penetrating effect on lipids and oil-soluble substances at frequencies other than the high frequency band. In this case, the value of the second parameter (=α1) is preferably 156 kHz or more, for example, with respect to the output mode M1 shown in FIG. 7 (or the output mode according to the output waveforms of FIGS. 7A to 7C). In this case, if there is a warming effect, there will be a diffusion effect, and the penetration effect will be good.

FIG. 17H is a table showing other test results regarding the specific target "tocopherol acetate." FIG. 17H shows the results when the test in the same manner as in FIG. 16A described above was conducted by changing the substance to tocopherol acetate.

The output waveform according to test condition C120 is an AC stimulation with a frequency of 1 MHz, and the output waveform according to test condition C121 is an AC stimulation with a frequency of 190 kHz.

From these tests, it was found that in the case of tocopherol acetate, 190 kHz alternating current stimulation and 1 MHz alternating current stimulation are more suitable than test condition C1.

FIG. 18 is an explanatory diagram of a control mode when multiple pieces of control information are used simultaneously. In the example shown in FIG. 18, control information associated with mode configuration information "M3+M4+M2" and control information associated with mode configuration information "M3+M2+M4" are used simultaneously. Note that the mode configuration information "M3+M4+M2" indicates that output mode M3, output mode M4, and output mode M2 are executed in this order (or any other order may be used, the same applies hereinafter), and the mode configuration information "M3+M2+M4" ” indicates that output mode M3, output mode M2, and output mode M4 are executed in this order. In this case, as schematically shown in FIG. 18, the process based on the control information to which the mode configuration information "M3+M4+M2" is associated (see section PT1 in FIG. 18) is associated with the mode configuration information "M3+M2+M4". (see section PT2 in FIG. 18) may be alternately and repeatedly executed.

In this way, even when using cosmetics or the like containing multiple active ingredients (objects), control (processing) based on each piece of control information associated with multiple control information IDs can be alternately and repeatedly executed.

Note that when using cosmetics or the like containing multiple active ingredients (objects), the blending ratio between the multiple objects may be reflected in the control. For example, in the example shown in FIG. 18, the object related to the control information associated with the mode configuration information "M3+M4+M2" is more complex than the object related to the control information associated with the mode configuration information "M3+M2+M4". If the ratio is significantly high, the process based on the control information associated with the mode configuration information "M3+M4+M2" is given priority over the process associated with the mode configuration information "M3+M2+M4" (for example, the number of repetitions) (or in a manner in which the standard execution time becomes longer).

Although each embodiment has been described in detail above, it is not limited to the specific embodiment, and various modifications and changes can be made within the scope of the claims. It is also possible to combine all or a plurality of the components of the embodiments described above.

For example, in the embodiment described above, the beauty device 4 can output control information according to various objects by cooperating with the user terminal 2 and the information processing device 3, but the present invention is not limited to this. For example, the beauty device 4 may be a dedicated device that operates based on control information corresponding to one or more specific objects. In this case, the beauty device 4 may be sold as a set with one or more specific objects. Alternatively, even if the beauty device 4 is capable of acquiring control information according to various objects, the beauty device 4 may operate based on the control information according to one or more specific objects as a default setting. may be set to . In this case as well, the beauty device 4 may be sold as a set with one or more specific objects.

In addition, in a modified example in which the beauty device 4 is a dedicated device that operates based on control information corresponding to one or more specific objects, a user terminal may be used as a component of the information processing system 1 according to the above-described embodiment. 2 and the information processing device 3 may be omitted.

Furthermore, in the embodiments described above, one or more objects are associated with each piece of various control information, but the number of types of control information may be only one. In this case, it is preferable that the one piece of control information is used together with one or more specific objects, but they do not need to be associated with each other. Similarly, in the embodiments described above, control information is associated with each of various objects, but the number of types of objects may be only one. In this case, the objects are preferably used together with dedicated control information, but do not need to be associated with each other.

Furthermore, in the embodiments described above, one object is associated with one piece of control information, but a plurality of pieces of control information may be associated with one object.

Furthermore, in the embodiment described above, the lower-order data 512 (see FIG. 5) forming the control information includes each value of the first parameter to the third parameter, but some of the values of the first parameter to the third parameter are included. may be omitted. Furthermore, the fourth parameter may include a parameter that defines a change pattern of the pair of electrodes that generate the output waveform. Such a fourth parameter is suitable for an electrode configuration in which a plurality of electrodes 40 are arranged in various ways. Furthermore, the fifth parameter may include a parameter that defines whether the output waveform is an attenuated waveform.

Furthermore, in the embodiments described above, the control information may be set for each model or type of beauty device 4. In this case, the control information can be adapted to the characteristics of various beauty devices 4.

Furthermore, in the above-described embodiment, the control information associated with one object includes various characteristics or properties of the one object, such as (1) properties related to the ease of solubility of the object in a solvent; It may be set based on at least one of 2) characteristics related to electrification, and (3) molecular weight or its attributes, but is not limited thereto. For example, the control information associated with one object may include at least one of these items, as well as the "pH value" of the entire cosmetic, "base", "blending ratio", and "effectiveness". etc. may also be taken into consideration.

Furthermore, in the embodiments described above, the processing executed by the beauty device 4 based on the control information is based on the electrical output waveform, but is not limited to this. For example, instead of or in addition to an electrical output waveform, there are methods that use heat from a heater etc., methods that use light such as LED (Light Emitting Diode) light and IPL (Intense Pulsed Light), methods that use ultrasound, and magnetism. Any one or more of a physical method, a method using electromagnetic waves, and a method using plasma may be used. In this case, a process may be implemented in which the electrode 40 is not utilized.

Furthermore, in the embodiments described above, the control information associated with one target object may be corrected based on information regarding the user who uses the object. For example, the control information may be corrected based on the user's attributes (for example, gender, age, race, etc.), the user's trouble information, questionnaire information such as skin quality, usage status of the beauty device 4, and the like.

Furthermore, in the embodiments described above, the control information associated with one object may be corrected according to the external environment at the time of use (for example, the intensity of ultraviolet rays, humidity, etc.). This is because the most effective control information may differ depending on the external environment at the time of use.

Furthermore, in the embodiment described above, the control information associated with one object may be set for each type of beauty device 4. In this case, the information processing device 3 may extract control information according to the type of beauty device 4 owned by the user who requested the control information.

Furthermore, in the embodiments described above, the control information associated with one object is mainly adapted so that the object penetrates into the human skin effectively. Not limited. For example, in electrical treatment, it has been found that there are objects that are likely to have effects other than penetration, such as electricity itself. That is, in addition to penetration, there are cases where the skin is activated and the skin becomes firmer and more elastic simply by the action of electricity, and there are objects that are suitable for use in this case. In addition, LEDs and electromagnetic waves have more significant effects on cell activation, promotion of blood circulation, and sterilization than on promoting penetration of objects, and there are objects that are suitable for use in such cases. Specifically, objects containing citric acid can have different physical sensations depending on their properties, such as electricity flowing through them more easily, and a smooth solvent transmitting heat faster than a gel-like object. The transmission of electrical stimulation can also change. Therefore, for objects that are not intended for penetration, control information other than the method of penetration into human skin may be associated with them, taking into account their properties, texture, and the like. In this case, for example, control information for realizing processing related to electrical stimulation (for example, an output waveform for high-frequency muscle electrical stimulation) is associated with an object through which electricity easily flows, and a component through which heat easily conducts ( Control information for realizing a processing method related to heating (for example, an output waveform for heating using radio waves) may be associated with an object containing a component (including a component as a base).

The following additional notes are further disclosed regarding each of the above embodiments.

[Additional note 1]
An operating method for operating a skin treatment device that processes human skin based on control information associated with an object that can be applied to human skin.

[Additional note 2]
The operating method according to supplementary note 1, wherein the control information represents two or more different types of predetermined processes that are caused to be executed by the skin treatment device continuously in chronological order.

[Additional note 3]
The operating method according to appendix 2, wherein the two or more types of predetermined processing include applying output waveforms having different characteristics to the human skin via a pair of electrodes provided in the skin treatment device.

[Additional note 4]
The two or more types of predetermined processing include a first type of predetermined processing in which the output waveform is an AC waveform, and a second type of predetermined processing in which the output waveform is a pulsed DC waveform, as described in Appendix 3. How it works.

[Additional note 5]
The two or more types of predetermined processing are a third type of predetermined processing in which the output waveform is an AC waveform, and in contrast to the first type of predetermined processing, at least one of the amplitude and frequency of the AC waveform is The operating method according to appendix 4, further comprising a third type of predetermined processing, one of which is different.

[Additional note 6]
At least one of the amplitude and frequency of the alternating current waveform is based on at least one of the properties related to the solubility of the target object in the solvent, and the molecular weight of the target object or its attributes. The operating method according to Supplementary note 4 or 5, which is set as follows.

[Additional note 7]
The operating method according to any one of appendices 4 to 6, wherein the positive and negative polarities of the DC waveform are set based on characteristics of the object related to charging.

[Additional note 8]
8. The operating method according to any one of Supplementary Notes 2 to 7, wherein the control information further represents execution times of each of the two or more types of predetermined processes or a ratio thereof.

[Additional note 9]
The control information is associated with each of the one or more objects that have at least one of the following: a property related to solubility in a solvent, a property related to electrification, and a molecular weight or an attribute thereof. The method according to any one of Supplementary Notes 1 to 8, wherein:

[Additional note 10]
A skin processing device that processes human skin based on control information associated with objects that can be applied to human skin.

[Additional note 11]
A program executed by a computer of a skin treatment device,
A program that causes the skin processing device to process human skin based on control information associated with an object that can be applied to human skin.

[Additional note 12]
A processing unit that controls a skin treatment device that processes human skin based on control information associated with an object that can be applied to human skin,
The information processing system is characterized in that the control information represents two or more different types of predetermined processes that are caused to be executed by the skin processing device continuously in time series.

[Additional note 13]
a storage unit that stores two or more types of control information associated with each of the plurality of different objects; and an object information acquisition unit that specifies or estimates one or more of the objects applied to the user's skin. further comprising:
The processing unit acquires, from the storage unit, the control information associated with one or more of the objects specified or estimated by the object information acquisition unit, and based on the acquired control information, The information processing system according to appendix 12, which controls a skin treatment device.

[Additional note 14]
When the processing unit acquires two or more types of the control information, the processing unit performs the two or more predetermined processes based on the first type of the control information and the two or more predetermined processes based on the second type of the control information. 14. The information processing system according to appendix 12 or 13, wherein the processing is executed continuously in chronological order via the skin processing device.

[Additional note 15]
A storage device that stores control information for controlling a skin treatment device that processes human skin, the storage device comprising:
The control information is associated with an object that can be applied to a person's skin, and includes information for causing the skin treatment device to successively perform two or more different types of predetermined processing in chronological order.

[Additional note 16]
The storage device according to supplementary note 15, which stores the control information associated with each of the plurality of objects.

[Additional note 17]
A storage device according to appendix 15 or 16,
When information that can identify one or more of the objects is acquired from the request source, the control information related to the one or more objects from the acquired information is extracted, and the extracted control information is added to the request. a data management device including a processing device for transmitting data to a source;

[Additional note 18]
A processing unit that controls a skin treatment device that processes human skin based on control information generated in association with an object that can be applied to human skin,
The information processing system is characterized in that the control information represents two or more different types of predetermined processes that are caused to be executed by the skin processing device continuously in time series.

1 Information processing system 2 User terminal 3 Information processing device 4 Beauty device 4a Operating section 4b Grip section 4c Operation button 30 Communication bus 31 Communication section 32 Storage section 33 Control section 40 Electrode 100 Control system 110 Control device 120 Drive circuit section 130 Output waveform Generating section 135 Transformer 140 Switching circuit section 150 Power supply 200 Electric circuit section

Claims

An operating method for operating a skin treatment device that treats human skin so that an object that can be applied to the human skin penetrates.
The target object includes, as a first target object, an active ingredient that is low molecular weight, water-soluble, and has a property of being easily positively charged;
The operating method according to claim 1, wherein at least one of a positive direct current stimulus and a high frequency alternating current stimulus is applied so as to penetrate the first object.
The operating method according to claim 2, wherein at least any two of a positive direct current stimulus, an alternating current stimulus of 900 kHz or more, and an alternating current stimulus of 10 kHz to 500 kHz is applied to the first object within a predetermined period. .
The target object includes, as a second target object, an active ingredient that is low molecular weight, water-soluble, and easily negatively charged;
The operating method according to claim 1, wherein at least one of a negative direct current stimulus and a high frequency alternating current stimulus is applied so as to penetrate the second object.
According to claim 4, at least any two of a negative direct current stimulus, an alternating current stimulus of 900 kHz or more, and an alternating current stimulus of 10 kHz to 500 kHz are applied within a predetermined period so that the second target object penetrates. Method of operation described.
The target object includes, as a third target object, an active ingredient of a low molecule, water-soluble, hardly charged in an aqueous solution, or an amphoteric electrolyte,
2. The method of claim 1, wherein a 200 kHz alternating current stimulus is applied to penetrate the third object.
The target object includes a lipid and oil-soluble active ingredient as a fourth target object,
2. The operating method according to claim 1, wherein an alternating current stimulus of 150 kHz or more is applied to penetrate the fourth object.
The target object includes a polymeric active ingredient as a fifth target object,
The operating method according to claim 1, wherein an alternating current stimulus of 100 kHz or less or a combination of an alternating current stimulus of 100 kHz or less and an alternating current stimulus of 1 MHz to 3 MHz is applied so that the fifth target object penetrates.
The target substances include cetyl tranexamic acid hydrochloride, tranexamic acid derivatives, niacinamide, pyridoxine hydrochloride and its derivatives, benzalkonium chloride, palmitoyl tripeptide-5, acetyl hexapeptide-8, diacetic acid as a first target substance. Contains at least one component of dipeptide diaminobutyroylbenzylamide, allantoin, ardioxa, carnitine HCl, basic amino acids lysine, arginine, histidine, tryptophan, ornithine, and ergothioneine,
According to claim 1, at least any two of a positive direct current stimulus, an alternating current stimulus of 900 kHz or more, and an alternating current stimulus of 10 kHz to 500 kHz are repeatedly applied for a predetermined period of time so that the first target object penetrates. How it works.
The target substance includes ascorbic acid, 4-methoxysalicylic acid potassium salt, disodium adenosine monophosphate, as well as L-ascorbic acid 2-glucoside, sodium L-ascorbyl phosphate, and magnesium ascorbyl phosphate, as a second target substance. , L-ascorbyl magnesium phosphate, disodium L-ascorbic acid sulfate, trisodium ascorbyl palmitate phosphate, ascorbic acid and its derivatives, sodium dl-α tocopheryl phosphate, zinc paraphenolsulfonate, salicylic acid and its sodium Salt, sodium lactate, sodium L- or DL-pyrrolidonecarboxylic acid solution, sodium L-glutamate, sodium L-aspartate, glycyrrhizic acid, dipotassium glycyrrhizinate, ammonium glycyrrhizinate, etc., glycyrrhizic acid and its salts, sodium guaiazulene sulfonate, Contains at least one component of lysine Na lauroylglutamate,
According to claim 1, at least any two of a negative direct current stimulus, an alternating current stimulus of 900 kHz or more, and an alternating current stimulus of 10 kHz to 500 kHz are repeatedly applied for a predetermined period of time so that the second object penetrates. Method of operation as described.
A skin treatment device that processes human skin so that an object that can be applied to the human skin penetrates.
A skin treatment method for treating human skin so that a target substance that can be applied to the human skin penetrates.
A program that causes a skin treatment device to treat a person's skin so that an object that can be applied to the person's skin penetrates.
A program that causes a skin treatment device to treat a person's skin in association with the characteristics of the object so that the object that can be applied to the person's skin penetrates.